Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium ascorbyl phosphate + fluoride is a combination therapeutic formulation used in oral care, specifically in dentifrices (toothpastes). Magnesium ascorbyl phosphate (MAP) is a stable, water-soluble derivative of Vitamin C that acts as an antioxidant and a precursor for collagen synthesis, which helps in maintaining the integrity of gingival tissues and reducing inflammation, redness, and bleeding associated with gingivitis. Fluoride, typically included as sodium fluoride or sodium monofluorophosphate, provides anti-caries protection by promoting the remineralization of dental enamel and inhibiting the metabolic processes of plaque-forming bacteria. This combination is primarily developed and marketed by companies like Lion Corporation for the treatment of gingivitis and the prevention of dental decay.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium ascorbyl phosphate + fluoride.